272 related articles for article (PubMed ID: 31286834)
1. MiR-124 reversed the doxorubicin resistance of breast cancer stem cells through STAT3/HIF-1 signaling pathways.
Liu C; Xing H; Guo C; Yang Z; Wang Y; Wang Y
Cell Cycle; 2019 Sep; 18(18):2215-2227. PubMed ID: 31286834
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-29a contributes to drug-resistance of breast cancer cells to adriamycin through PTEN/AKT/GSK3β signaling pathway.
Shen H; Li L; Yang S; Wang D; Zhong S; Zhao J; Tang J
Gene; 2016 Nov; 593(1):84-90. PubMed ID: 27523474
[TBL] [Abstract][Full Text] [Related]
3. Schisandrin A reverses doxorubicin-resistant human breast cancer cell line by the inhibition of P65 and Stat3 phosphorylation.
Zhang ZL; Jiang QC; Wang SR
Breast Cancer; 2018 Mar; 25(2):233-242. PubMed ID: 29181822
[TBL] [Abstract][Full Text] [Related]
4. Cucurbitacin D induces cell cycle arrest and apoptosis by inhibiting STAT3 and NF-κB signaling in doxorubicin-resistant human breast carcinoma (MCF7/ADR) cells.
Ku JM; Kim SR; Hong SH; Choi HS; Seo HS; Shin YC; Ko SG
Mol Cell Biochem; 2015 Nov; 409(1-2):33-43. PubMed ID: 26169986
[TBL] [Abstract][Full Text] [Related]
5. MiR-375 inhibits the stemness of breast cancer cells by blocking the JAK2/STAT3 signaling.
Zhao Q; Liu Y; Wang T; Yang Y; Ni H; Liu H; Guo Q; Xi T; Zheng L
Eur J Pharmacol; 2020 Oct; 884():173359. PubMed ID: 32738343
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy-elicited exosomal miR-378a-3p and miR-378d promote breast cancer stemness and chemoresistance via the activation of EZH2/STAT3 signaling.
Yang Q; Zhao S; Shi Z; Cao L; Liu J; Pan T; Zhou D; Zhang J
J Exp Clin Cancer Res; 2021 Apr; 40(1):120. PubMed ID: 33823894
[TBL] [Abstract][Full Text] [Related]
7. miRNA expression patterns in chemoresistant breast cancer tissues.
Lv J; Xia K; Xu P; Sun E; Ma J; Gao S; Zhou Q; Zhang M; Wang F; Chen F; Zhou P; Fu Z; Xie H
Biomed Pharmacother; 2014 Oct; 68(8):935-42. PubMed ID: 25451164
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-222 promotes drug resistance to doxorubicin in breast cancer via regulation of miR-222/bim pathway.
Dai H; Xu LY; Qian Q; Zhu QW; Chen WX
Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31273056
[TBL] [Abstract][Full Text] [Related]
9. Stat3/Oct-4/c-Myc signal circuit for regulating stemness-mediated doxorubicin resistance of triple-negative breast cancer cells and inhibitory effects of WP1066.
Cheng CC; Shi LH; Wang XJ; Wang SX; Wan XQ; Liu SR; Wang YF; Lu Z; Wang LH; Ding Y
Int J Oncol; 2018 Jul; 53(1):339-348. PubMed ID: 29750424
[TBL] [Abstract][Full Text] [Related]
10. Systematic analysis of gene expression pattern in has-miR-760 overexpressed resistance of the MCF-7 human breast cancer cell to doxorubicin.
Lv J; Fu Z; Shi M; Xia K; Ji C; Xu P; Lv M; Pan B; Dai L; Xie H
Biomed Pharmacother; 2015 Feb; 69():162-9. PubMed ID: 25661353
[TBL] [Abstract][Full Text] [Related]
11. miR-20b modulates VEGF expression by targeting HIF-1 alpha and STAT3 in MCF-7 breast cancer cells.
Cascio S; D'Andrea A; Ferla R; Surmacz E; Gulotta E; Amodeo V; Bazan V; Gebbia N; Russo A
J Cell Physiol; 2010 Jul; 224(1):242-9. PubMed ID: 20232316
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-132 and microRNA-212 mediate doxorubicin resistance by down-regulating the PTEN-AKT/NF-κB signaling pathway in breast cancer.
Xie M; Fu Z; Cao J; Liu Y; Wu J; Li Q; Chen Y
Biomed Pharmacother; 2018 Jun; 102():286-294. PubMed ID: 29567542
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-574 enhances doxorubicin resistance through down-regulating SMAD4 in breast cancer cells.
Sun FD; Wang PC; Luan RL; Zou SH; Du X
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(5):1342-1350. PubMed ID: 29565492
[TBL] [Abstract][Full Text] [Related]
14. The radio-sensitizing effect of xanthohumol is mediated by STAT3 and EGFR suppression in doxorubicin-resistant MCF-7 human breast cancer cells.
Kang Y; Park MA; Heo SW; Park SY; Kang KW; Park PH; Kim JA
Biochim Biophys Acta; 2013 Mar; 1830(3):2638-48. PubMed ID: 23246576
[TBL] [Abstract][Full Text] [Related]
15. Isoharringtonine inhibits breast cancer stem-like properties and STAT3 signaling.
Chen W; Wang H; Cheng M; Ni L; Zou L; Yang Q; Cai X; Jiao B
Biomed Pharmacother; 2018 Jul; 103():435-442. PubMed ID: 29679903
[TBL] [Abstract][Full Text] [Related]
16. miR-140-5p inhibits the proliferation and enhances the efficacy of doxorubicin to breast cancer stem cells by targeting Wnt1.
Wu D; Zhang J; Lu Y; Bo S; Li L; Wang L; Zhang Q; Mao J
Cancer Gene Ther; 2019 Mar; 26(3-4):74-82. PubMed ID: 30032164
[TBL] [Abstract][Full Text] [Related]
17. Sabutoclax, pan-active BCL-2 protein family antagonist, overcomes drug resistance and eliminates cancer stem cells in breast cancer.
Hu Y; Yagüe E; Zhao J; Wang L; Bai J; Yang Q; Pan T; Zhao H; Liu J; Zhang J
Cancer Lett; 2018 Jun; 423():47-59. PubMed ID: 29496539
[TBL] [Abstract][Full Text] [Related]
18. Apigenin overcomes drug resistance by blocking the signal transducer and activator of transcription 3 signaling in breast cancer cells.
Seo HS; Ku JM; Choi HS; Woo JK; Lee BH; Kim DS; Song HJ; Jang BH; Shin YC; Ko SG
Oncol Rep; 2017 Aug; 38(2):715-724. PubMed ID: 28656316
[TBL] [Abstract][Full Text] [Related]
19. Fat mass and obesity-associated protein (FTO) mediates signal transducer and activator of transcription 3 (STAT3)-drived resistance of breast cancer to doxorubicin.
Wang Y; Cheng Z; Xu J; Lai M; Liu L; Zuo M; Dang L
Bioengineered; 2021 Dec; 12(1):1874-1889. PubMed ID: 34076564
[TBL] [Abstract][Full Text] [Related]
20. EMMPRIN Down-regulating miR-106a/b Modifies Breast Cancer Stem-like Cell Properties via Interaction with Fibroblasts Through STAT3 and HIF-1α.
Liu Y; Zhang J; Sun X; Li M
Sci Rep; 2016 Jun; 6():28329. PubMed ID: 27325313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
